chr11-63290194-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039752.4(SLC22A10):āc.29T>Cā(p.Val10Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,608,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039752.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC22A10 | NM_001039752.4 | c.29T>C | p.Val10Ala | missense_variant | 1/10 | ENST00000332793.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC22A10 | ENST00000332793.11 | c.29T>C | p.Val10Ala | missense_variant | 1/10 | 1 | NM_001039752.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000899 AC: 22AN: 244788Hom.: 0 AF XY: 0.0000679 AC XY: 9AN XY: 132560
GnomAD4 exome AF: 0.000118 AC: 172AN: 1456048Hom.: 0 Cov.: 30 AF XY: 0.000101 AC XY: 73AN XY: 723650
GnomAD4 genome AF: 0.000171 AC: 26AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.29T>C (p.V10A) alteration is located in exon 1 (coding exon 1) of the SLC22A10 gene. This alteration results from a T to C substitution at nucleotide position 29, causing the valine (V) at amino acid position 10 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at